SCHEDULE: ING Groep Discloses 6.47% Stake in NEOGEN Corp

ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have jointly reported a beneficial ownership of 6.47% in NEOGEN Corp's common stock.

Summary

• ING Groep N.V. and its wholly-owned subsidiary, ING Capital Markets LLC, have filed a Schedule 13G, indicating a passive investment.
• They collectively beneficially own 14,060,900 shares of NEOGEN Corp's common stock.
• This ownership represents approximately 6.47% of NEOGEN Corp's total outstanding common stock.
• The percentage is calculated based on 217,298,626 shares of common stock outstanding as of August 31, 2025.
• NEOGEN Corp's shares outstanding data was reported in its Quarterly Report on Form 10-Q filed with the SEC on September 10, 2025.
• Both ING Groep N.V. and ING Capital Markets LLC hold shared voting power and shared dispositive power over these shares.

Sentiment

Score: 7

Explanation: The filing indicates a significant passive investment by a major financial institution, which is generally a positive signal of confidence in the issuer, NEOGEN Corp. No negative information is presented within the context of this ownership disclosure.

Positives

• Increased institutional ownership by a major financial institution like ING Groep N.V. can signal confidence in NEOGEN Corp's long-term prospects.
• The filing indicates a passive investment, suggesting no immediate intent to influence control or management, which can be viewed as a stable form of institutional support.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding NEOGEN Corp's future performance or operations.

Industry Context

This filing reflects a significant institutional investment in the animal and food safety diagnostics industry, indicating potential long-term interest from a major global financial group in companies operating within this sector.

Related Party Transactions

• ING Capital Markets LLC is a wholly-owned subsidiary of ING Groep N.V., and they are filing this Schedule 13G jointly as related entities.

Stakeholder Impact

• Shareholders: Increased institutional ownership may be viewed positively, potentially enhancing market confidence and liquidity for NEOGEN Corp's stock.
• Management: No direct impact on management or operations is indicated, as the investment is passive and does not suggest an intent to influence control.

Key Dates

Recommendation

The filing indicates a significant passive ownership stake by ING Groep N.V. and its subsidiary in NEOGEN Corp. While this signals institutional confidence, it does not provide new fundamental information about NEOGEN's operational performance or strategic direction that would warrant a 'buy' or 'sell' recommendation. The substantial stake from a reputable financial institution could offer a degree of market stability, suggesting a 'hold' position for existing investors.

Keywords

NEOGEN Corp, ING Groep NV, ING Capital Markets LLC, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Ownership, Passive Investment, 640491106